Murtada Alsaif reports on a new nationwide Swedish cohort study that explores the real-world effectiveness of oral and depot antipsychotics for people with schizophrenia.
The post Should people with schizophrenia be offered depot antipsychotics as first line treatment? appeared first on National Elf Service.